Leukemia 2021 May 03
A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma.
Related Questions
New comment by at Emory University ( March 22, 2022)
Dr. @Stanton C. Goldman,
Was G-CSF used routinely with this regimen?